Published online April 3, 2006
PEDIATRICS Vol. 117 No. 4 April 2006, pp. S71-S77 (doi:10.1542/10.1542/peds.2005-2000D)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kwok, M. Y. Articles by Kelly, K. J. Search for Related Content PubMed PubMed Citation Articles by Kwok, M. Y. Articles by Kelly, K. J. Related Collections Asthma Social Bookmarking                         What's this?

SUPPLEMENT ARTICLE

National Asthma Education and Prevention Program Severity Classification as a Measure of Disease Burden in Children With Acute Asthma

Maria Y. Kwok, MD, MPH^a, Christine M. Walsh-Kelly, MD^a, Marc H. Gorelick, MD, MSCE^a, Laura Grabowski, MS^b and Kevin J. Kelly, MD^b

^a Divisions of Emergency Medicine and
^b Allergy/Immunology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

OBJECTIVE. To examine the association between the National Asthma Education and Prevention Program (NAEPP) severity classification and other measures of burden of disease in children with acute asthma.

METHODS. We performed a cross-sectional study of 750 children <18 years of age with a physician diagnosis of asthma and treated in an emergency department (ED) for acute asthma exacerbation. Subjects were assigned to 1 of 4 levels of severity (mild intermittent, mild persistent, moderate persistent, or severe persistent). Assignments followed 3 methods: the report of symptom frequency alone (standard method); symptom frequency and reported controller-medication use (modified method); or the additive modified method in which the symptom frequency and reported controller-medication use were assigned numeric values and a score was calculated. An asthma-specific quality-of-life score was calculated by using the Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF). The number of ED visits and hospital admissions for asthma over the previous 12 months was collected also. Differences between severity groups were compared with analysis of variance, and the proportion of variance explained (r²) was calculated.

RESULTS. Using the standard classification method, 55% of subjects had mild intermittent asthma, 21% had mild persistent asthma, 14% had moderate persistent asthma, and 10% had severe persistent asthma. Among those classified as having mild intermittent asthma by symptoms alone, 22% were reclassified as having persistent asthma when controller medications were accounted for. With all 3 scoring methods, mean ITG-CASF scores decreased significantly with each increasing level of severity. However, the magnitude of this association was modest. There was a significant but limited association between severity level and mean number of ED visits and hospitalizations.

CONCLUSION. NAEPP severity classification alone provides an incomplete picture of the burden of disease in children with asthma.

---

Key Words: asthma • severity classification • children • disease burden

Abbreviations: NAEPP—National Asthma Education and Prevention Program • ED—emergency department • QoL—quality of life • MI—mild intermittent asthma • MildP—mild persistent asthma • ModP—moderate persistent asthma • SevP—severe persistent asthma • ITG-CASF—Integrated Therapeutics Group Child Asthma Short Form

---

Accepted Dec 6, 2005.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Zervas, E. Oikonomidou, E. Kainis, M. Kokkala, K. Petroheilou, and M. Gaga Review: Control of asthma Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 141 - 148. [Abstract] [PDF]

				P. M. O'Byrne How much is too much? The treatment of mild asthma Eur. Respir. J., September 1, 2007; 30(3): 403 - 406. [Full Text] [PDF]